Similar response to adalimumab in patients with active Crohn's disease either naive to biologic agents or with prior loss of response or intolerance to infliximab. [electronic resource]
Producer: 20100726Description: 85-90 p. digitalISSN:- 0048-7848
- Adalimumab
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Crohn Disease -- drug therapy
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Gastrointestinal Agents -- therapeutic use
- Humans
- Infliximab
- Injections, Subcutaneous
- Male
- Middle Aged
- Risk Factors
- Smoking -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.